<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 3)*
Polymedica Industries, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
731738-10-0
- --------------------------------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 Pages
SEC 1745 (2-95)
<PAGE> 2
CUSIP NO. 731738-10-0 13G PAGE 2 OF 5 PAGES
<TABLE>
<S> <C>
- --------------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Commonwealth BioVentures, Inc.
04-298-4136
- --------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / / (b) /X/
- --------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
- --------------------------------------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY ------------------------------------------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH 38,409 (1)
REPORTING ------------------------------------------------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH 0
------------------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
38,409 (1)
- ---------------------------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
38,409 (1)
- --------------------------------------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.51%
- --------------------------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------------------------------------
(1) Beneficial ownership expressly disclaimed
</TABLE>
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 5 pages
<PAGE> 3
Page 3 of 5
-----------
SCHEDULE 13G
------------
ITEM 1.
- ------
(a) Name of Issuer:
PolyMedica Industries, Inc.
(b) Address of Issuer's Principal Executive Offices:
11 State Street
Woburn, MA 01801
ITEM 2.
- ------
(a) Name of Person Filing:
Commonwealth BioVentures Inc.
(b) Address of Principal Business Office or, if none, Residence:
4 Milk Street
Portland, ME 04101
(c) Citizenship:
Massachusetts
(d) Title of Class of Securities:
Common
(e) CUSIP Number:
731738-10-0
ITEM 3. Persons filing pursuant to Rule 13d-1(b) or 13d-2(b):
- ------
N/A
<PAGE> 4
Page 4 of 5
-----------
ITEM 4. Ownership:
- ------
(a) Amount beneficially owned: 3,409 shares by a limited partnership of
which the reporting person is the general partner and 35,000 by a limited
partnership of which the reporting person is the general partner of the general
partner. Ownership of all shares is expressly disclaimed.
(b) Percent of Class: .51%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote: 38,409
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 38,409
ITEM 5. Ownership of Five Percent or Less of a Class:
- ------
If the statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [X].
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person:
- ------
N/A
ITEM 7. Identification and Classification of the Subsidiary Which
- ------ Acquired the Security Being Reported on By the Parent Holding Company:
N/A
ITEM 8. Identification and Classification of Members of the Group:
- ------
N/A
ITEM 9. Notice of Dissolution of Group:
- ------
N/A
<PAGE> 5
Page 5 of 5
-----------
ITEM 10. Certification:
- -------
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
COMMONWEALTH BIOVENTURES INC.
Date: May ____, 1996 By: _______________________________
Robert G. Foster, President
